Komentář ke studii LEADER

Title in English Commentary on the LEADER study


Year of publication 2017
Type Article in Proceedings
Conference Diabetologie 2017
MU Faculty or unit

Faculty of Medicine

Field Cardiovascular diseases incl. cardiosurgery
Keywords diabetes mellitus; cardiovascular safety
Description LEADER study investigates cardiovascular safety of liraglutide in patients with diabetes mellitus, and cardiovascular disease or at risk thereof. Study has proved the drug efficacy as well as the safety of its administration, including reduction of all-cause mortality.

You are running an old browser version. We recommend updating your browser to its latest version.

More info